Recombinant TNFRSF17 (Ispectamab Biosimilar) antibody
The Humanized Monoclonal anti-TNFRSF17 (Ispectamab Biosimilar) antibody is suitable to detect TNFRSF17 (Ispectamab Biosimilar) in samples from Human.
Catalog No. ABIN7829516
$211.02
Plus shipping costs $50.00
50 μg
Shipping to:
United States
Delivery in 30 to 41 Business Days
Quick Overview for Recombinant TNFRSF17 (Ispectamab Biosimilar) antibody (ABIN7829516)
Target
TNFRSF17 (Ispectamab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Humanized
Clonality
Monoclonal
Conjugate
This TNFRSF17 (Ispectamab Biosimilar) antibody is un-conjugated
Grade
Research Grade
-
-
Purpose
- Anti-BCMA(ispectamab biosimilar) mAb
-
Isotype
- IgG1
-
-
-
-
Comment
-
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Please see Certificate of Analysis for specific instructions of reconstitution.
-
Buffer
- Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.
-
Storage
- -20 °C,-80 °C
-
Storage Comment
- Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.
-
Expiry Date
- 12 months
-
-
- TNFRSF17 (Ispectamab Biosimilar)
-
Alternative Name
- Ispectamab Biosimilar
-
Target Type
- Biosimilar
-
Background
-
Synonyms Target:BCM,BCMA,CD269,TNFRSF13A,TNFRSF17
Synonyms Antibody:BMS-986352,BMS 986352,BMS986352 -
UniProt
- Q02223
Target
-
You are here:
